• Explore /
  • Poster
  • / Evaluation of <em>BRCA1</em>/2 mutation status among women with triple-negative breast cancer.

Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer.

Abstract Poster

Authors

null

Axel Muendlein

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch, Austria

Axel Muendlein , Bettina Rhode , Klaus Gasser , Elena Kinz , Heinz Drexel , Wera Hofmann , Verena Schindler , Rita Kapoor , Thomas Decker , Alois Lang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Triple-Negative Breast Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 1119)

DOI

10.1200/jco.2014.32.15_suppl.1119

Abstract #

1119

Poster Bd #

212

Abstract Disclosures

Similar Posters

First Author: N. M. Tun

Poster

2021 ASCO Annual Meeting

Serial circulating tumor DNA samples from patients with metastatic breast cancer and <em>BRCA1/2</em> mutations.

Serial circulating tumor DNA samples from patients with metastatic breast cancer and BRCA1/2 mutations.

First Author: Katharine Collier

First Author: Wassim Abida

First Author: Philipp Harter